News Chart NFL Biosciences

Stocks

ALNFL

FR0014003XT0

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:55:00 2026-10-15 EDT			5-day change	1st Jan Change
0.5780 ^EUR	-0.86%		-12.42%	-50.93%

10-06	NFL Biosciences Provides Progress Update on NFL-101 and NFL-102 Clinical Programs in Smoking Cessation	CI
07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI

eac47c702d5c8cd01ce6a89f6a3c3ee.fklpeTF6lNPfKn3QMzQmuG_8O41L_PYvlzZXmc9JhCM.NhFfO31O8OHmRCiYC01y9xvIU-YOyb5qpFsa7oh-t2onCCtIeynnkphOCg~37763d10726e9fa8b12839ba64f30d4d